InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (3 ops.)
Insider track record
OtherDisclosed buys
0
Disclosed sells
3
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the full record of transactions filed by Watanabe Todd, See Remarks. Officer active across 1 company, notably Arcutis Biotherapeutics, Inc.. Aggregated, 3 reports have been logged. Split: 0 buy · 3 sells. Total volume traded: €1.9m. History available since 4 August 2025. The latest transaction was disclosed on 28 October 2025 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Declarations3 total
40,000 shares@ US$25.025850.0% of flowCommon StockSEC:0001801061-25-000008
40,000 shares@ US$25.02580.032% mcap50.0% of flowCommon StockSEC:0001801061-25-000008:0
11,547 shares@ US$14.32667.7% of flowCommon StockSEC:0001787306-25-000119:0
3 of 3 declarations
About Watanabe Todd
Todd Watanabe is involved in various functions at Arcutis Biotherapeutics, Inc. His role includes specific responsibilities that contribute to the company's development and strategy. His expertise is an asset to the organization.
